138 related articles for article (PubMed ID: 21246261)
1. Malignant transformation of 293 cells induced by ectopic expression of human Nanog.
Lin YL; Han ZB; Xiong FY; Tian LY; Wu XJ; Xue SW; Zhou YR; Deng JX; Chen HX
Mol Cell Biochem; 2011 May; 351(1-2):109-16. PubMed ID: 21246261
[TBL] [Abstract][Full Text] [Related]
2. Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts.
Park YS; Nemeño JG; Choi NY; Lee JI; Ko K; Choi SC; Kim WS; Han DW; Tapia N; Ko K
Biol Chem; 2016 Mar; 397(3):249-55. PubMed ID: 26733157
[TBL] [Abstract][Full Text] [Related]
3. Functional evidence that the self-renewal gene NANOG regulates human tumor development.
Jeter CR; Badeaux M; Choy G; Chandra D; Patrawala L; Liu C; Calhoun-Davis T; Zaehres H; Daley GQ; Tang DG
Stem Cells; 2009 May; 27(5):993-1005. PubMed ID: 19415763
[TBL] [Abstract][Full Text] [Related]
4. Identification of a putative transactivation domain in human Nanog.
Oh JH; Do HJ; Yang HM; Moon SY; Cha KY; Chung HM; Kim JH
Exp Mol Med; 2005 Jun; 37(3):250-4. PubMed ID: 16000880
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of the human NANOG protein.
Chang DF; Tsai SC; Wang XC; Xia P; Senadheera D; Lutzko C
Stem Cells; 2009 Apr; 27(4):812-21. PubMed ID: 19350681
[TBL] [Abstract][Full Text] [Related]
6. Nanog transforms NIH3T3 cells and targets cell-type restricted genes.
Piestun D; Kochupurakkal BS; Jacob-Hirsch J; Zeligson S; Koudritsky M; Domany E; Amariglio N; Rechavi G; Givol D
Biochem Biophys Res Commun; 2006 Apr; 343(1):279-85. PubMed ID: 16540082
[TBL] [Abstract][Full Text] [Related]
7. Involvement of NANOG upregulation in malignant progression of human cells.
Li Y; Higashiyama S; Shimakage M; Kawahara K; Yutsudo M; Watari A
DNA Cell Biol; 2013 Mar; 32(3):104-10. PubMed ID: 23427894
[TBL] [Abstract][Full Text] [Related]
8. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
9. Two potent transactivation domains in the C-terminal region of human NANOG mediate transcriptional activation in human embryonic carcinoma cells.
Do HJ; Lee WY; Lim HY; Oh JH; Kim DK; Kim JH; Kim T; Kim JH
J Cell Biochem; 2009 Apr; 106(6):1079-89. PubMed ID: 19229867
[TBL] [Abstract][Full Text] [Related]
10. NANOG upregulates c-Jun oncogene expression through binding the c-Jun promoter.
Lin Y; Xiong F; Zhou Y; Wu X; Liu F; Xue S; Chen H
Mol Carcinog; 2015 Nov; 54(11):1407-16. PubMed ID: 25213759
[TBL] [Abstract][Full Text] [Related]
11. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.
Kamada M; Mitsui Y; Matsuo T; Takahashi T
Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211
[TBL] [Abstract][Full Text] [Related]
12. The pluripotency factor NANOG promotes the formation of squamous cell carcinomas.
Palla AR; Piazzolla D; Alcazar N; Cañamero M; Graña O; Gómez-López G; Dominguez O; Dueñas M; Paramio JM; Serrano M
Sci Rep; 2015 May; 5():10205. PubMed ID: 25988972
[TBL] [Abstract][Full Text] [Related]
13. Nanog induces hyperplasia without initiating tumors.
Fischedick G; Wu G; Adachi K; Araúzo-Bravo MJ; Greber B; Radstaak M; Köhler G; Tapia N; Iacone R; Anastassiadis K; Schöler HR; Zaehres H
Stem Cell Res; 2014 Sep; 13(2):300-15. PubMed ID: 25173648
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells.
Hamid T; Malik MT; Kakar SS
Mol Cancer; 2005 Jan; 4(1):3. PubMed ID: 15649325
[TBL] [Abstract][Full Text] [Related]
15. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
16. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.
Hayashi Y; Caboni L; Das D; Yumoto F; Clayton T; Deller MC; Nguyen P; Farr CL; Chiu HJ; Miller MD; Elsliger MA; Deacon AM; Godzik A; Lesley SA; Tomoda K; Conklin BR; Wilson IA; Yamanaka S; Fletterick RJ
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4666-71. PubMed ID: 25825768
[TBL] [Abstract][Full Text] [Related]
17. NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway.
Sun C; Sun L; Jiang K; Gao DM; Kang XN; Wang C; Zhang S; Huang S; Qin X; Li Y; Liu YK
Int J Biochem Cell Biol; 2013 Jun; 45(6):1099-108. PubMed ID: 23474366
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
19. Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.
Ye T; Li J; Sun Z; Liu Y; Kong L; Zhou S; Tang J; Wang J; Xing HR
Cancer Med; 2019 Mar; 8(3):1232-1245. PubMed ID: 30740909
[TBL] [Abstract][Full Text] [Related]
20. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
